Preclinical News and Research

RSS
Discovery Labs to present lucinactant Phase 2a clinical study results at NACFC Conference

Discovery Labs to present lucinactant Phase 2a clinical study results at NACFC Conference

Octapharma USA accepts applications for 25th Anniversary Grants Program

Octapharma USA accepts applications for 25th Anniversary Grants Program

Cubist third quarter total net revenues increase 13% to $162.1M

Cubist third quarter total net revenues increase 13% to $162.1M

BIOTRONIK announces European release of TI Trend Chart

BIOTRONIK announces European release of TI Trend Chart

NIH awards two new grants to develop Avidocin platform

NIH awards two new grants to develop Avidocin platform

Moores Cancer Center files IND application for topical NexACT-based formulation

Moores Cancer Center files IND application for topical NexACT-based formulation

Omeros receives additional NIDA grant for clinical studies in Addiction program

Omeros receives additional NIDA grant for clinical studies in Addiction program

NanoViricides files financial year end annual report with SEC

NanoViricides files financial year end annual report with SEC

Kineta awarded second NIH contract to identify new drug targets and candidates

Kineta awarded second NIH contract to identify new drug targets and candidates

Top citations for scientific paper on Inovio's SynCon DNA vaccines and ID DNA delivery technology

Top citations for scientific paper on Inovio's SynCon DNA vaccines and ID DNA delivery technology

XenoPort to present XP23829 preclinical data at ECTRIMS meeting

XenoPort to present XP23829 preclinical data at ECTRIMS meeting

OptiMedica to feature Catalys Precision Laser System at Ophthalmology annual meeting

OptiMedica to feature Catalys Precision Laser System at Ophthalmology annual meeting

Genmab and Lundbeck enter agreement to develop antibody therapeutics

Genmab and Lundbeck enter agreement to develop antibody therapeutics

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

Cardiogenesis initiates enrollment in PHOENIX System Feasibility Study

Cardiogenesis initiates enrollment in PHOENIX System Feasibility Study

ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer

ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer

Researchers investigate 'friendly bacteria' to kill bone cancer cells

Researchers investigate 'friendly bacteria' to kill bone cancer cells

First presentation of anti-HER2 antibody-drug conjugate as first-line therapy for advanced breast cancer

First presentation of anti-HER2 antibody-drug conjugate as first-line therapy for advanced breast cancer

Helix completes GLP toxicology study milestone in L-DOS47 development program

Helix completes GLP toxicology study milestone in L-DOS47 development program

Halozyme Therapeutics to advance core proprietary programs through key clinical inflection points

Halozyme Therapeutics to advance core proprietary programs through key clinical inflection points

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.